Antiproliferative and apoptotic potential of Chinese medicinal plants against MCF-7 (luminal A), HCC1954 (HER2+) and Hs578t breast cancer cells

Nuria de Pedro, Ma Rosario Chica, Juan Cantizani, Bastien Cautain, Francisca Vicente, Lin Zhang, Anjaneya S. Ravipati, Narsimha Reddy, M. Karthik, Cheang Khoo, Trevor D. Bailey, Sundar R. Koyyalamudi

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Breast cancer is a significant cause of death among women worldwide. Medicinal plant extracts with large amounts of polyphenolic compounds, which are antioxidants, can have an important role in cancer prevention. The purpose of this study is to test in vitro the antiproliferative activities of the ethanolic and aqueous extracts of selected Chinese medicinal plants against three human breast cancer cell lines [MCF-7 (luminal A); HCC1954 (HER2+); Hs578t (triple negative)] and one normal cell line [MCF-10A]. The ethanolic extracts of Polygonum cuspidatum, Rheum officinale, Eucomia ulmoides, Lysinachia christinae, Rhizoma Alpinae, Sarcandra glabre, Scutellaria baicalensis, Smilax glabra and Atractyloides macrocephala showed potent anti-cancer activity with little or no toxicity to normal cells. The apoptosis test was carried out for one of the active plant extract (S. baicalensis) and the results were found to be very significant. The plant extracts investigated in this study have significant anticancer activity against the breast cancer cell lines tested. Further investigation is required to isolate and elucidate the structure of the compounds responsible for the observed activity.
    Original languageEnglish
    Pages (from-to)454-467
    Number of pages14
    JournalPhytopharmacology
    Volume4
    Issue number3
    Publication statusPublished - 2013

    Keywords

    • medicine, Chinese
    • herbs
    • therapeutic use
    • breast
    • cancer
    • plant polyphenols

    Fingerprint

    Dive into the research topics of 'Antiproliferative and apoptotic potential of Chinese medicinal plants against MCF-7 (luminal A), HCC1954 (HER2+) and Hs578t breast cancer cells'. Together they form a unique fingerprint.

    Cite this